10X Genomics, Inc. (TXG)
63.79
-1.33
(-2.04%)
USD |
NASDAQ |
Aug 24, 16:00
63.79
0.00 (0.00%)
After-Hours: 20:00
10X Genomics Total Assets (Quarterly) : 1.030B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.030B |
| March 31, 2026 | 1.016B |
| December 31, 2025 | 1.041B |
| September 30, 2025 | 1.027B |
| June 30, 2025 | 979.97M |
| March 31, 2025 | 903.39M |
| December 31, 2024 | 918.64M |
| September 30, 2024 | 937.79M |
| June 30, 2024 | 929.67M |
| March 31, 2024 | 922.91M |
| December 31, 2023 | 965.14M |
| September 30, 2023 | 948.54M |
| June 30, 2023 | 989.64M |
| March 31, 2023 | 1.014B |
| December 31, 2022 | 1.029B |
| September 30, 2022 | 996.21M |
| June 30, 2022 | 1.002B |
| March 31, 2022 | 1.003B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.019B |
| September 30, 2021 | 990.57M |
| June 30, 2021 | 977.58M |
| March 31, 2021 | 954.03M |
| December 31, 2020 | 929.34M |
| September 30, 2020 | 1.043B |
| June 30, 2020 | 582.80M |
| March 31, 2020 | 610.38M |
| December 31, 2019 | 605.92M |
| September 30, 2019 | 572.82M |
| June 30, 2019 | 155.59M |
| March 31, 2019 | |
| December 31, 2018 | 124.31M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 75.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Twist Bioscience Corp. | 672.44M |
| Alamar Biosciences, Inc. (California) | 390.98M |
| Personalis, Inc. | 312.14M |
| Adaptive Biotechnologies Corp. | 640.68M |
| Champions Oncology, Inc. | 26.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 204.52M |
| Shareholders Equity (Quarterly) | 825.55M |
| Debt to Equity Ratio | 0.0954 |
| Current Ratio | 5.693 |
| Net Debt Paydown Yield | 0.01% |